BWM
RKDA icon

Bullock Wealth Management’s Arcadia Biosciences RKDA Stock Holding History

Bullock Wealth Management’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$749 Hold
1,000
– – ﹤0.01% 583
2026
Q1 		$1.4K Buy
+1,000
New +$1.96K ﹤0.01% 573

Other funds holding RKDA

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Bullock Wealth Management's RKDA Position: Q2 2026 in Review

Bullock Wealth Management held its Arcadia Biosciences (RKDA) position steady in Q2 2026 at 1,000 shares worth $749. The position accounts for ﹤0.01% of the portfolio, ranked #583.

Bullock Wealth Management first reported a position in RKDA in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.4K in Q1 2026. 18 funds tracked by Wall St. Rank hold RKDA as of Q2 2026.

  • Bullock Wealth Management held 1,000 shares of Arcadia Biosciences worth $749 as of Q2 2026.
  • Bullock Wealth Management left its Arcadia Biosciences share count unchanged in Q2 2026.
  • Arcadia Biosciences made up ﹤0.01% of Bullock Wealth Management's portfolio in Q2 2026, its #583 holding.
  • Bullock Wealth Management first reported a position in Arcadia Biosciences in Q1 2026 and has held it in 2 quarters since.
  • Bullock Wealth Management's Arcadia Biosciences position peaked at $1.4K in Q1 2026.
  • 18 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.